HHS amended the Public Readiness and Emergency Preparedness (PREP) Act to allow pharmacists to order and administer select therapeutics given orally, subcutaneously, or intramuscularly, including current and future medications that are approved, authorized, cleared, or licensed to treat or prevent COVID-19. This includes subcutaneous monoclonal antibodies. Licensed pharmacists, licensed or registered pharmacy interns, and qualified pharmacy technicians who meet the criteria in the amendment are also authorized to administer certain COVID-19 therapeutics. To be eligible an ACPE continuing education program must be completed and you must have current certification in CPR.
Stay informed, subscribe to the
Prescribe Right Pharmaceutical Pipeline Tracker
Latest Tweets from Prescribe Right